SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-98-010517
Filing Date
1998-12-09
Accepted
1998-12-09 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO A SCHEDULE 13D SC 13D/A 13639
2 THE SUBSCRIPTION AGREEMENT, DATED 11/11/98 EX-99.1 19776
3 THE ACCEPTANCE LETTER FROM THE CO. AND BIOCHEM EX-99.2 1983
4 CERTIFICATE EVIDENCING $9,000,000 EX-99.4 40475
  Complete submission text file 0000950123-98-010517.txt   78067
Mailing Address
Business Address 10150 OLD COLUMBIA ROAD COLUMBIA MD 21046 3014198400
NORTH AMERICAN VACCINE INC (Subject) CIK: 0000856573 (see all company filings)

IRS No.: 980121241 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49421 | Film No.: 98765897
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Filed by) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances